Skip to main content

To: Wes Streeting

Expedite the MHRA granting emergency approval of Sipivibart (Kavigale)

Sipavibart's approval is crucial. E.G by leveraging the International Recognition Procedure, (MHRA) could expediently approve this life-changing medication. Even if initially this was done for emergency use.It would align the UK's stance with EU,USA ensuring equitable health protection for all!

Why is this important?

After five long years, the battle against COVID-19 feels never-ending, especially for those of us who are immunovunerable. Living with Blood Cancer + Hypogammaglobulinemia, I find myself still shielding from a virus that has ceased to be a common threat to the general population thanks to the use of vaccines. For in excess of 500,000 reality is starkly different; the existing vaccines don't provide us with the immunity they do for others. 
 
There is hope with Sipavibart, (Kavigale) made by Astra Zeneca a promising treatment that could offer us protection. The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have already recognized this by granting emergency use approval. 
 
I urge the MHRA to act swiftly and decisively. This drug's approval would not only represent progress in the fight against COVID-19 but also symbolize that our needs are not forgotten. Please join me in advocating for those who are most at risk and in need of protection. Sign this petition to call on the MHRA to approve Sipavibart for Emergency use. Thus allowing us access to the protection we rightfully deserve and granting us the ability to regain some normality in our lives!

 

Category

Updates

2025-05-15 16:31:07 +0100

25 signatures reached

2025-05-13 18:31:03 +0100

10 signatures reached